A decrease in HK2 expression in CRC cells upon downregulating RUNDC3A − AS1 underscores its probable regulatory mechanism involving HK2 and glycolysis in CRC, warranting further mechanistic studies. The gene discussed is RUNDC3A; the disease is colorectal carcinoma.